|Title||A newly described cutaneous reaction at sites of insulin pump use in a child with Type 1 diabetes.|
|Publication Type||Journal Article|
|Year of Publication||2021|
|Authors||Perez VA, Husain S, Magro CM, Strom MA, Williams KM, Levin LE|
|Date Published||2021 Jan|
|Keywords||Blood Glucose, Blood Glucose Self-Monitoring, Child, Diabetes Mellitus, Type 1, Humans, Hypoglycemic Agents, Insulin Infusion Systems|
Continuous subcutaneous insulin infusion (CSII), or insulin pumps, with or without continuous glucose monitoring (CGM) devices have become the standard of care for patients with type 1 diabetes. While increasingly popular, a wide range of reported skin reactions to CSII and CGM devices was found. We present this case of a pyogenic granuloma-like neutrophilic and granulomatous response to an insulin pump to increase awareness of a previously uncharacterized cutaneous adverse reaction at insulin pump infusion sites.
|Alternate Journal||Pediatr Dermatol|
Cynthia M. Magro, M.D.